In a large observational study of 102,014 subjects with malignant neoplasms in Japan, 0.47% of subjects treated with G-CSF developed aortitis compared to only 0.01% in subjects who did not receive G-CSF [9]. The gene discussed is CSF3; the disease is aortitis.